Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base-Reference-Cited by-同舟云学术

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base

Published:2017-05 Issue:3 Volume:18 Page:286-292
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Steuer Conor E.,Behera Madhusmita,Liu Yuan,Fu Chao,Gillespie Theresa W.,Saba Nabil F.,Shin Dong M.,Pillai Rathi N.,Pakkala Suchita,Owonikoko Taofeek K.,Khuri Fadlo R.,Ramalingam Suresh S.

Funder

National Institutes of Health/National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart;Travis,2004

2. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results database analysis;Yendamuri;Surgery,2012

3. Sarcomatoid neoplasms of the lung and pleura;Travis;Arch Pathol Lab Med,2010

4. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma;Vieira;J Thorac Oncol,2013

5. Next-generation sequencing of pulmonary sarcomatoid carcinoma reveals high frequency of actionable MET gene mutations;Liu;J Clin Oncol,2016

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010;BMC Cancer;2024-08-02

2. Lazarus Response to Selpercatinib for Bleeding Colic Metastasis in a Patient With RET Fusion-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report;Cureus;2024-07-23

3. Pulmonary sarcomatoid carcinoma: A rare case report, diagnostic dilemma and review of literature;Medicine;2024-07-05

4. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC;Frontiers in Immunology;2024-05-02

5. Case report: Pathological complete response induced by immunochemotherapy in a case of Pulmonary Sarcomatoid Carcinoma staged IIIA-N2;Frontiers in Immunology;2024-04-08